Prosecution Insights
Last updated: April 19, 2026
Application No. 18/033,950

CURABLE COMPOSITION AND SEALANT

Non-Final OA §102§103§112
Filed
Apr 26, 2023
Examiner
CAI, WENWEN
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Kuraray Co. Ltd.
OA Round
1 (Non-Final)
60%
Grant Probability
Moderate
1-2
OA Rounds
3y 2m
To Grant
80%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allow Rate
509 granted / 850 resolved
-5.1% vs TC avg
Strong +20% interview lift
Without
With
+19.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
74 currently pending
Career history
924
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
43.6%
+3.6% vs TC avg
§102
17.4%
-22.6% vs TC avg
§112
27.9%
-12.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 850 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1-10 in the reply filed on 11/19/2025 is acknowledged. Claim 11 is withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 11/9/2025. Claim Objections Claim 1 objected to because of the following informalities: “in a side chain” should be “in the side chain” due to inherent antecedent basis. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (B) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-10 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. Claim 4 recites a melt viscosity which heavily depends on measuring temperature and shear rate/frequency. Without citing a shear rate, the claimed viscosity is meaningless from scientific point of view because the claimed range can always be obtained by adjusting shear rate. For purposes of expediting prosecution, any value would read on the claimed range. Where applicant acts as his or her own lexicographer to specifically define a term of a claim contrary to its ordinary meaning, the written description must clearly redefine the claim term and set forth the uncommon definition so as to put one reasonably skilled in the art on notice that the applicant intended to so redefine that claim term. Process Control Corp. v. HydReclaim Corp., 190 F.3d 1350, 1357, 52 USPQ2d 1029, 1033 (Fed. Cir. 1999). The term “beta-farnesene” is used by the claim to mean “a compound having three carbon-carbon double bonds,” while the accepted meaning is PNG media_image1.png 76 360 media_image1.png Greyscale which has four double bonds. The term is indefinite because the specification does not clearly redefine the term. Claim 1 recites number of moles of double bond which is defined in the specification by a formula related to vinyl content. However, the specification discloses the vinyl content is related to conjugated diene units bonded through 1,13-bond and 3,13 -bond. What are 1,13-bond and 3,13 -bond? The specification discloses “the vinyl content is calculated, using .sup.1H-NMR, from an area ratio of a peak derived from a structural unit derived from a conjugated diene bonded by the 1,2-bond, the 3,4-bond (case other than β-farnesene), and the 3,13-bond (case of β-farnesene) to a peak derived from a structural unit derived from a conjugated diene bonded by the 1,4-bond (case other than β-farnesene) and the 1,13-bond (case of β-farnesene).” It indicates the vinyl content is a ratio between a structure derived from 3,13 bond to a structure derived from 1,13 bond, such a ratio could be a number greater than 1, however, vinyl content should be a value less than 1. Clarification is required. For purposes of expediting prosecution, the limitation is interpreted by its literal meaning. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-8, 10 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kanbara et al (US 2017/0327681). Claims 1-4, 6-8, 10: Kanbara teaches a composition comprising a beta-farnesene homopolymer, a crosslinking agent, a filler, a solid rubber which reads on another polymer, a foaming agent (table 3, examples 3-4, 0097). The polyfarnesene has Mw of 37,000, Mw/Mn of 1.2, Mn of 30833 which equals to 151 degree of polymerization. For polyfarnesene, 1,4-bond results in 2 double bonds in the side chain, other structures have 3 double bonds in the side chain. Therefore, the above polyfarnesene has at least 302 mols of double bonds in the side chain per mole of the polymer. Claim 5: Kanbara teaches the crosslinking agent can be sulfur or peroxide [0078]. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kanbara et al (US 2017/0327681) in view of Kadowaki et al (JPS62295979). In setting forth this rejection a machine translation of JPS62295979 has been relied upon and all citations to paragraph numbers in the discussion below are with respect to the machine translation USPGPub. Kanbara teaches the limitations of claim 1, as discussed above. Kanbara further teaches the composition comprising a crosslinking aid, a multifunctional unsaturated compound, such as ethylene dimethacrylate, trimethylol propane trimethacrylate etc. [0095]. Kanbara does not teach a crosslinking aid like claimed. However, Kadowaki discloses a curable composition and teaches trimethylol propane trimethacrylate and acryloyl terminated polybutadiene oligomer are interchangeable in a curable composition (page 3). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to utilize an acryloyl terminated polybutadiene oligomer as a crosslinking aid in the composition of Kanbara because they are interchangeable in a curable composition. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WENWEN CAI whose telephone number is (571)270-3590. The examiner can normally be reached on M-F 9am-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on (571)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WENWEN CAI/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Apr 26, 2023
Application Filed
Jan 12, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600886
RESINS FOR ADHESIVE BONDING OF FABRICS
2y 5m to grant Granted Apr 14, 2026
Patent 12590201
DEGRADATION PROMOTER FOR ALIPHATIC POLYESTER BIODEGRADABLE RESIN, BIODEGRADABLE RESIN COMPOSITION, AND METHOD FOR PROMOTING DEGRADATION OF ALIPHATIC POLYESTER BIODEGRADABLE RESIN
2y 5m to grant Granted Mar 31, 2026
Patent 12559592
BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME
2y 5m to grant Granted Feb 24, 2026
Patent 12552956
PHOTOPOLYMERIZABLE TYPE DENTAL SURFACE COATING COMPOSITION
2y 5m to grant Granted Feb 17, 2026
Patent 12534556
CURABLE COMPOSITION, CURED ARTICLE USING SAME, AND METHOD FOR PRODUCING CURED ARTICLE
2y 5m to grant Granted Jan 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
60%
Grant Probability
80%
With Interview (+19.8%)
3y 2m
Median Time to Grant
Low
PTA Risk
Based on 850 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month